HEADER TRANSFERASE/INHIBITOR 15-FEB-21 7LQP TITLE RAPID DEVELOPMENT OF POTENT INHIBITORS OF THE HIV INTEGRASE-LEDGF TITLE 2 INTERACTION BY FRAGMENT-LINKING USING OFF-RATE SCREENING COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTEGRASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CORE DOMAIN (UNP RESIDUES 57-212); COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 11676; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, HIV INTEGRASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.A.GORMAN,M.W.PARKER REVDAT 1 23-FEB-22 7LQP 0 JRNL AUTH M.A.GORMAN,M.W.PARKER JRNL TITL RAPID DEVELOPMENT OF POTENT INHIBITORS OF THE HIV JRNL TITL 2 INTEGRASE-LEDGF INTERACTION BY FRAGMENT-LINKING USING JRNL TITL 3 OFF-RATE SCREENING JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.18.2_3874: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : TWIN_LSQ_F REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.07 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.52 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 13.150 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 17645 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.870 REMARK 3 FREE R VALUE TEST SET COUNT : 3423 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.5200 - 5.6200 0.91 1593 159 0.2098 0.2592 REMARK 3 2 5.6200 - 4.4600 0.89 1563 182 0.1420 0.2075 REMARK 3 3 4.4600 - 3.9000 0.90 1564 174 0.1439 0.1948 REMARK 3 4 3.9000 - 3.5400 0.90 1578 165 0.1478 0.2121 REMARK 3 5 3.5400 - 3.2900 0.90 1580 172 0.1672 0.2395 REMARK 3 6 3.2900 - 3.1000 0.90 1561 164 0.1869 0.2544 REMARK 3 7 3.1000 - 2.9400 0.90 1585 182 0.1797 0.2405 REMARK 3 8 2.9400 - 2.8100 0.91 1606 167 0.1858 0.2743 REMARK 3 9 2.8100 - 2.7100 0.90 1564 176 0.1960 0.2428 REMARK 3 10 2.7000 - 2.6100 0.90 1560 176 0.2038 0.2957 REMARK 3 11 2.6100 - 2.5300 0.90 1576 176 0.2129 0.2380 REMARK 3 12 2.5300 - 2.4600 0.90 1557 170 0.2196 0.2565 REMARK 3 13 2.4600 - 2.3900 0.90 1621 174 0.2121 0.2530 REMARK 3 14 2.3900 - 2.3300 0.90 1519 172 0.2339 0.3617 REMARK 3 15 2.3300 - 2.2800 0.90 1609 168 0.2513 0.3457 REMARK 3 16 2.2800 - 2.2300 0.90 1574 166 0.2600 0.3212 REMARK 3 17 2.2300 - 2.1900 0.90 1534 170 0.2517 0.3303 REMARK 3 18 2.1900 - 2.1500 0.90 1621 179 0.2607 0.2898 REMARK 3 19 2.1500 - 2.1100 0.90 1490 169 0.2737 0.2856 REMARK 3 20 2.1100 - 2.0700 0.77 1419 148 0.3014 0.3529 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.640 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 2369 REMARK 3 ANGLE : 0.755 3205 REMARK 3 CHIRALITY : 0.044 353 REMARK 3 PLANARITY : 0.004 389 REMARK 3 DIHEDRAL : 20.304 315 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7LQP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-FEB-21. REMARK 100 THE DEPOSITION ID IS D_1000254858. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-AUG-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9775 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17645 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.070 REMARK 200 RESOLUTION RANGE LOW (A) : 46.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.16500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.07 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.13 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.72600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: BI-PYRAMID REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.2 M AMMONIUM SULFATE, 100 MM SODIUM REMARK 280 IODIDE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 68.99950 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 103.49925 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 34.49975 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -198.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 50 REMARK 465 HIS A 51 REMARK 465 GLY A 52 REMARK 465 GLU A 53 REMARK 465 VAL A 54 REMARK 465 ASP A 55 REMARK 465 SER A 56 REMARK 465 TYR A 143 REMARK 465 ASN A 144 REMARK 465 PRO A 145 REMARK 465 GLN A 146 REMARK 465 SER A 147 REMARK 465 GLN A 148 REMARK 465 GLY A 149 REMARK 465 VAL A 150 REMARK 465 ILE A 151 REMARK 465 LYS A 211 REMARK 465 GLU A 212 REMARK 465 MET B 50 REMARK 465 HIS B 51 REMARK 465 GLY B 52 REMARK 465 GLU B 53 REMARK 465 VAL B 54 REMARK 465 ASP B 55 REMARK 465 PRO B 90 REMARK 465 ALA B 91 REMARK 465 GLU B 92 REMARK 465 PRO B 142 REMARK 465 TYR B 143 REMARK 465 ASN B 144 REMARK 465 PRO B 145 REMARK 465 GLN B 146 REMARK 465 SER B 147 REMARK 465 GLN B 148 REMARK 465 GLY B 149 REMARK 465 LYS B 211 REMARK 465 GLU B 212 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 409 O HOH B 411 1.99 REMARK 500 OE1 GLN B 137 O HOH B 401 2.00 REMARK 500 O HOH B 418 O HOH B 430 2.03 REMARK 500 O4 SO4 A 309 O HOH A 401 2.05 REMARK 500 OE1 GLU A 138 O HOH A 402 2.06 REMARK 500 O HOH A 408 O HOH A 435 2.07 REMARK 500 O HOH A 422 O HOH A 441 2.08 REMARK 500 O HOH B 402 O HOH B 419 2.11 REMARK 500 O VAL A 110 O HOH A 403 2.13 REMARK 500 OD1 ASP B 202 O HOH B 402 2.14 REMARK 500 OE1 GLN A 168 O HOH A 404 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 58 -72.14 -66.21 REMARK 500 ILE A 141 66.04 -117.30 REMARK 500 ARG A 187 161.36 104.75 REMARK 500 ILE A 191 -76.41 -76.08 REMARK 500 SER B 57 124.62 -35.63 REMARK 500 GLU B 87 149.10 -175.63 REMARK 500 ILE B 191 131.74 -176.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ARG A 187 LYS A 188 -132.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6W42 RELATED DB: PDB REMARK 900 HIV INTEGRASE CORE DOMAIN IN COMPLEX WITH INHIBITOR 2-(5-METHYL-2- REMARK 900 (2-(THIOPHEN-2-YL)ETHYNYL)-1-BENZOFURAN-3-YL)ACETIC ACID DBREF 7LQP A 57 212 UNP Q76353 Q76353_9HIV1 57 212 DBREF 7LQP B 57 212 UNP Q76353 Q76353_9HIV1 57 212 SEQADV 7LQP MET A 50 UNP Q76353 EXPRESSION TAG SEQADV 7LQP HIS A 51 UNP Q76353 EXPRESSION TAG SEQADV 7LQP GLY A 52 UNP Q76353 EXPRESSION TAG SEQADV 7LQP GLU A 53 UNP Q76353 EXPRESSION TAG SEQADV 7LQP VAL A 54 UNP Q76353 EXPRESSION TAG SEQADV 7LQP ASP A 55 UNP Q76353 EXPRESSION TAG SEQADV 7LQP SER A 56 UNP Q76353 EXPRESSION TAG SEQADV 7LQP GLU A 131 UNP Q76353 TRP 131 CONFLICT SEQADV 7LQP LYS A 185 UNP Q76353 PHE 185 CONFLICT SEQADV 7LQP GLU A 209 UNP Q76353 GLN 209 CONFLICT SEQADV 7LQP MET B 50 UNP Q76353 EXPRESSION TAG SEQADV 7LQP HIS B 51 UNP Q76353 EXPRESSION TAG SEQADV 7LQP GLY B 52 UNP Q76353 EXPRESSION TAG SEQADV 7LQP GLU B 53 UNP Q76353 EXPRESSION TAG SEQADV 7LQP VAL B 54 UNP Q76353 EXPRESSION TAG SEQADV 7LQP ASP B 55 UNP Q76353 EXPRESSION TAG SEQADV 7LQP SER B 56 UNP Q76353 EXPRESSION TAG SEQADV 7LQP GLU B 131 UNP Q76353 TRP 131 CONFLICT SEQADV 7LQP LYS B 185 UNP Q76353 PHE 185 CONFLICT SEQADV 7LQP GLU B 209 UNP Q76353 GLN 209 CONFLICT SEQRES 1 A 163 MET HIS GLY GLU VAL ASP SER SER PRO GLY ILE TRP GLN SEQRES 2 A 163 LEU ASP CSO THR HIS LEU GLU GLY LYS VAL ILE LEU VAL SEQRES 3 A 163 ALA VAL HIS VAL ALA SER GLY TYR ILE GLU ALA GLU VAL SEQRES 4 A 163 ILE PRO ALA GLU THR GLY GLN GLU THR ALA TYR PHE LEU SEQRES 5 A 163 LEU LYS LEU ALA GLY ARG TRP PRO VAL LYS THR VAL HIS SEQRES 6 A 163 THR ASP ASN GLY SER ASN PHE THR SER THR THR VAL LYS SEQRES 7 A 163 ALA ALA CYS GLU TRP ALA GLY ILE LYS GLN GLU PHE GLY SEQRES 8 A 163 ILE PRO TYR ASN PRO GLN SER GLN GLY VAL ILE GLU SER SEQRES 9 A 163 MET ASN LYS GLU LEU LYS LYS ILE ILE GLY GLN VAL ARG SEQRES 10 A 163 ASP GLN ALA GLU HIS LEU LYS THR ALA VAL GLN MET ALA SEQRES 11 A 163 VAL PHE ILE HIS ASN LYS LYS ARG LYS GLY GLY ILE GLY SEQRES 12 A 163 GLY TYR SER ALA GLY GLU ARG ILE VAL ASP ILE ILE ALA SEQRES 13 A 163 THR ASP ILE GLU THR LYS GLU SEQRES 1 B 163 MET HIS GLY GLU VAL ASP SER SER PRO GLY ILE TRP GLN SEQRES 2 B 163 LEU ASP CSO THR HIS LEU GLU GLY LYS VAL ILE LEU VAL SEQRES 3 B 163 ALA VAL HIS VAL ALA SER GLY TYR ILE GLU ALA GLU VAL SEQRES 4 B 163 ILE PRO ALA GLU THR GLY GLN GLU THR ALA TYR PHE LEU SEQRES 5 B 163 LEU LYS LEU ALA GLY ARG TRP PRO VAL LYS THR VAL HIS SEQRES 6 B 163 THR ASP ASN GLY SER ASN PHE THR SER THR THR VAL LYS SEQRES 7 B 163 ALA ALA CYS GLU TRP ALA GLY ILE LYS GLN GLU PHE GLY SEQRES 8 B 163 ILE PRO TYR ASN PRO GLN SER GLN GLY VAL ILE GLU SER SEQRES 9 B 163 MET ASN LYS GLU LEU LYS LYS ILE ILE GLY GLN VAL ARG SEQRES 10 B 163 ASP GLN ALA GLU HIS LEU LYS THR ALA VAL GLN MET ALA SEQRES 11 B 163 VAL PHE ILE HIS ASN LYS LYS ARG LYS GLY GLY ILE GLY SEQRES 12 B 163 GLY TYR SER ALA GLY GLU ARG ILE VAL ASP ILE ILE ALA SEQRES 13 B 163 THR ASP ILE GLU THR LYS GLU MODRES 7LQP CSO A 65 CYS MODIFIED RESIDUE MODRES 7LQP CSO B 65 CYS MODIFIED RESIDUE HET CSO A 65 7 HET CSO B 65 7 HET IOD A 301 1 HET IOD A 302 1 HET IOD A 303 1 HET IOD A 304 1 HET SO4 A 305 5 HET SO4 A 306 5 HET SO4 A 307 5 HET SO4 A 308 5 HET SO4 A 309 5 HET SO4 A 310 5 HET IOD B 301 1 HET IOD B 302 1 HET SO4 B 303 5 HET SO4 B 304 5 HET SO4 B 305 5 HET SO4 B 306 5 HET SO4 B 307 5 HET SO4 B 308 5 HET YAV B 309 58 HETNAM CSO S-HYDROXYCYSTEINE HETNAM IOD IODIDE ION HETNAM SO4 SULFATE ION HETNAM YAV 2-[2-[2-[3-[2-[2-[2-[[3-[2-[3-(2-HYDROXY-2-OXOETHYL)-5- HETNAM 2 YAV METHYL-1-BENZOFURAN-2- HETNAM 3 YAV YL]ETHYNYL]PHENYL]CARBONYLAMINO]ETHOXY]ETHOXY]ETHYLCAR HETNAM 4 YAV BAMOYL]PHENYL]ETHYNYL]-5-METHYL-1-BENZOFURAN-3- HETNAM 5 YAV YL]ETHANOIC ACID FORMUL 1 CSO 2(C3 H7 N O3 S) FORMUL 3 IOD 6(I 1-) FORMUL 7 SO4 12(O4 S 2-) FORMUL 21 YAV C46 H40 N2 O10 FORMUL 22 HOH *75(H2 O) HELIX 1 AA1 GLY A 94 TRP A 108 1 15 HELIX 2 AA2 GLY A 118 THR A 122 5 5 HELIX 3 AA3 SER A 123 GLY A 134 1 12 HELIX 4 AA4 SER A 153 ARG A 166 1 14 HELIX 5 AA5 ASP A 167 ALA A 169 5 3 HELIX 6 AA6 HIS A 171 LYS A 186 1 16 HELIX 7 AA7 SER A 195 ILE A 208 1 14 HELIX 8 AA8 GLY B 94 GLY B 106 1 13 HELIX 9 AA9 GLY B 118 THR B 122 5 5 HELIX 10 AB1 SER B 123 GLY B 134 1 12 HELIX 11 AB2 MET B 154 ARG B 166 1 13 HELIX 12 AB3 ASP B 167 ALA B 169 5 3 HELIX 13 AB4 HIS B 171 LYS B 186 1 16 HELIX 14 AB5 SER B 195 GLU B 209 1 15 SHEET 1 AA1 5 ILE A 84 VAL A 88 0 SHEET 2 AA1 5 LYS A 71 HIS A 78 -1 N ALA A 76 O GLU A 85 SHEET 3 AA1 5 ILE A 60 LEU A 68 -1 N THR A 66 O ILE A 73 SHEET 4 AA1 5 THR A 112 THR A 115 1 O HIS A 114 N LEU A 63 SHEET 5 AA1 5 LYS A 136 PHE A 139 1 O GLU A 138 N VAL A 113 SHEET 1 AA2 5 ILE B 84 VAL B 88 0 SHEET 2 AA2 5 LYS B 71 HIS B 78 -1 N ALA B 76 O GLU B 85 SHEET 3 AA2 5 ILE B 60 LEU B 68 -1 N THR B 66 O ILE B 73 SHEET 4 AA2 5 THR B 112 THR B 115 1 O HIS B 114 N TRP B 61 SHEET 5 AA2 5 LYS B 136 PHE B 139 1 O GLU B 138 N VAL B 113 LINK C ASP A 64 N CSO A 65 1555 1555 1.33 LINK C CSO A 65 N THR A 66 1555 1555 1.33 LINK C ASP B 64 N CSO B 65 1555 1555 1.33 LINK C CSO B 65 N THR B 66 1555 1555 1.33 CISPEP 1 GLY A 189 GLY A 190 0 -0.33 CRYST1 46.421 46.421 137.999 90.00 90.00 90.00 P 43 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021542 0.000000 0.000000 0.00000 SCALE2 0.000000 0.021542 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007246 0.00000